Top compounds associated with response to NXN


Feature Type Standardized
Nominal ANOVA
mRNA A-804598 CTRPv2 pan-cancer AAC 0.13 0.01
mRNA prochlorperazine CTRPv2 pan-cancer AAC -0.1 0.01
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.01
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.1 0.01
mRNA clofarabine CTRPv2 pan-cancer AAC -0.08 0.01
mRNA OSU-03012 GDSC1000 pan-cancer AAC 0.095 0.01
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC 0.094 0.01
mRNA XL765 CTRPv2 pan-cancer AAC 0.1 0.01
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.01
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.093 0.01
Download CSV